Maximus director Michael Warren adds shares via dividend reinvestment
Maximus, Inc. director Michael J. Warren reported small increases in his company stock holdings.
Rhea-AI Filing Summary
Maximus, Inc. director Michael J. Warren reported small increases in his company stock holdings. On 11/28/2025, he acquired 14.403 shares of Maximus common stock at a price of $86.111 per share, marked as a purchase. On 12/01/2025, he received an additional 39.07 shares with a stated price of $0 per share.
After these transactions, Warren beneficially owned 15,524.345 shares of Maximus common stock directly. The filing explains that the first transaction reflects shares purchased through a dividend reinvestment program, while the second represents dividend equivalent rights credited on previously awarded restricted stock units, each equivalent in value to one share of Maximus common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 39.07 | $0.00 | $0.00 |
| Purchase | Common Stock | 14.403 | $86.111 | $1K |
Footnotes (2)
- F1. Shares purchased via dividend reinvestment.
- F2. Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of Maximus common stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Maximus (MMS) director Michael J. Warren report in this Form 4?
Director Michael J. Warren reported acquiring additional Maximus common stock in two small transactions, increasing his directly held beneficial ownership to 15,524.345 shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.